Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-05
1997-12-30
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514300, 546123, 546156, A61K 3147, C07D215233, C07D47104
Patent
active
057030944
ABSTRACT:
The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in the 7-position by an unsaturated bicyclic amine radical, their salts, processes for their preparation and antibacterial compositions comprising these compounds
REFERENCES:
patent: 4988709 (1991-01-01), Ogata
patent: 4990517 (1991-02-01), Petersen
patent: 5026856 (1991-06-01), Yatsunami
patent: 5371090 (1994-12-01), Petersen
patent: 5464796 (1995-11-01), Petersen et al.
patent: 5498615 (1996-03-01), Kim
V.G. Blaschke, Angew. Chem., vol. 92, pp. 14-25, (1980).
P. Newman, "Optical Resolution Procedures for Chemical Compounds" vol. 1, Optical Resolutioin Information Center, Manhattan College, Riverdale, N.Y. (1978).
Bremm Klaus Dieter
Endermann Rainer
Petersen Uwe
Ruther Michael
Schenke Thomas
Bayer Aktiengesellschaft
Huang Evelyn
Ivy C. Warren
LandOfFree
Quinolone- and naphthyridonecarboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolone- and naphthyridonecarboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone- and naphthyridonecarboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-202559